Findings in a recent study have linked aspirin with lower mortality rates accounted due to stomach, oesophageal or colon cancer. It has been suggested that majority of the healthy people, who consumed aspirin every day, cut short 40% of chances of dying from the cancer types.
Researchers from the American Cancer Society surveyed more than 100,000 healthy people, aged above 60. The people were inquired about their intake of aspirin at regular intervals.
The study emphasized that a dose of aspirin taken daily can lower the risk of dying from other cancer types also by 12%. Thus, in total mortality rates administered due to cancer can be reduced by 16%.
Earlier studies in the same concerns have provided with similar results. This recent study has added to an already known fact that the drug can be beneficiary for health.
Previously doctors recommended the drug to all those in their middle ages, who have the disease in family history. However, it was advised to take lose doses.
The researchers of the study, which has been published in the Journal of the National Cancer Institute, said, “Even a relatively modest benefit with respect to overall cancer mortality could still meaningfully influence the balances of risks and benefits of prophylactic (protective) aspirin use”.
Good News USA
- Vodafone NZ’s new ‘Red Home’ packages will offer UFB and 150 TV channels
- Vodafone NZ’s full-year profit plunged by more than two-thirds to $56 million
- Vodafone adding 34 European countries to ‘AU$5 per day’ international roaming option
- Telstra launches its new ‘Every Day Connect Data Share Packages’
- Voyager signs “multimillion-dollar deal” with submarine cable group Hawaiki